Research Article

Efficacy analysis between ultrasound and cytology criteria in the differentiation of malignant and benign thyroid nodules: TIRADS versus BETHESDA

Volume: 6 Number: 2 March 27, 2023
EN

Efficacy analysis between ultrasound and cytology criteria in the differentiation of malignant and benign thyroid nodules: TIRADS versus BETHESDA

Abstract

Aim: Thyroid nodules (TNs) are abnormal masses of different structures and sizes to be detected promptly. The present study aimed to investigate the relationship between Bethesda and TIRADS and their diagnostic efficiency in histopathologically diagnosed malign TNs. Material and Method: 475 patients with TNs enrolled in this cross-sectional research. Laboratory parameters and clinical thyroid history were obtained from the automation system and analyzed retrospectively. They have been staged according to TIRADS, and the neck is evaluated in suspicious lymph nodes. FNAB results are then tracked for Bethesda staging. Results: TIRADS showed a good sensitivity at the rate of 74.5% and average specificity at 68.1% for TNs. Bethesda had a higher sensitivity at 80.1% and 95.2% specificity rates. The positive predictive (98.1 vs. 88.2) and negative predictive (13 vs. 23.6) values were higher for Bethesda than TIRADS. The diagnostic accuracy for Bethesda was 79%. According to the ROC, Bethesda had a more expansive area under curve (0.81) than TIRADS (0.63). FNAC was a better diagnostic method than ultrasonography in evaluating thyroid nodules (p<0.001). Conclusion: The risk of malignancy increased parallel to the increased Bethesda and TIRADS. While both scores helped predict malignancy, Bethesda is essential to physicians in assisting the discrimination of malign and benign TNs.

Keywords

References

  1. de Siqueira RA, Rodrigues A, Miamae LM, Tomimori EK, Silveira EA. Thyroid nodules in severely obese patients: frequency and risk of malignancy on ultrasonography. Endocr Res 2020; 45: 9-16.
  2. Daniels KE, Xu J, Liu JB, et al. Diagnostic value of TI-RADS classification system and next generation genetic sequencing in indeterminate thyroid nodules. Acad Radiol 2021; 28: 1685-91.
  3. Gungor K, Dokuzeylul Gungor N. Antithyroid antibodies may predict serum beta HCG levels and biochemical pregnancy losses in euthyroid women with IVF single embryo transfer. Gynecol Endocrinol 2021; 37: 702-5.
  4. Zhu Y, Sang Q, Jia S, Wang Y, Deyer T. Deep neural networks could differentiate Bethesda class III versus class IV/V/VI. Ann Transl Med 2019; 7: 231.
  5. Bian J, Wang R, Lin M. Ultrasonic S-Detect mode for the evaluation of thyroid nodules: A meta-analysis. Medicine (Baltimore) 2022; 101: e29991.
  6. Staibano P, Forner D, Noel CW, et al. Ultrasonography and fine-needle aspiration in indeterminate thyroid nodules: a systematic review of diagnostic test accuracy. Laryngoscope 2022; 132: 242-51.
  7. Ferrarazzo G, Camponovo C, Deandrea M, Piccardo A, Scappaticcio L, Trimboli P. Suboptimal accuracy of ultrasound and ultrasound-based risk stratification systems in detecting medullary thyroid carcinoma should not be overlooked. Findings from a systematic review with meta-analysis. Clin Endocrinol (Oxf) 2022; 97: 532-40.
  8. Nie W, Zhu L, Yan P, Sun J. Thyroid nodule ultrasound accuracy in predicting thyroid malignancy based on TIRADS system. Adv Clin Exp Med 2022; 31: 597-606.

Details

Primary Language

English

Subjects

Health Care Administration

Journal Section

Research Article

Publication Date

March 27, 2023

Submission Date

January 4, 2023

Acceptance Date

February 13, 2023

Published in Issue

Year 2023 Volume: 6 Number: 2

APA
Deniz, M. S., Sarı, K., & Özturk, O. (2023). Efficacy analysis between ultrasound and cytology criteria in the differentiation of malignant and benign thyroid nodules: TIRADS versus BETHESDA. Journal of Health Sciences and Medicine, 6(2), 405-409. https://doi.org/10.32322/jhsm.1229238
AMA
1.Deniz MS, Sarı K, Özturk O. Efficacy analysis between ultrasound and cytology criteria in the differentiation of malignant and benign thyroid nodules: TIRADS versus BETHESDA. J Health Sci Med / JHSM. 2023;6(2):405-409. doi:10.32322/jhsm.1229238
Chicago
Deniz, Muzaffer Serdar, Kutay Sarı, and Oğuz Özturk. 2023. “Efficacy Analysis Between Ultrasound and Cytology Criteria in the Differentiation of Malignant and Benign Thyroid Nodules: TIRADS versus BETHESDA”. Journal of Health Sciences and Medicine 6 (2): 405-9. https://doi.org/10.32322/jhsm.1229238.
EndNote
Deniz MS, Sarı K, Özturk O (March 1, 2023) Efficacy analysis between ultrasound and cytology criteria in the differentiation of malignant and benign thyroid nodules: TIRADS versus BETHESDA. Journal of Health Sciences and Medicine 6 2 405–409.
IEEE
[1]M. S. Deniz, K. Sarı, and O. Özturk, “Efficacy analysis between ultrasound and cytology criteria in the differentiation of malignant and benign thyroid nodules: TIRADS versus BETHESDA”, J Health Sci Med / JHSM, vol. 6, no. 2, pp. 405–409, Mar. 2023, doi: 10.32322/jhsm.1229238.
ISNAD
Deniz, Muzaffer Serdar - Sarı, Kutay - Özturk, Oğuz. “Efficacy Analysis Between Ultrasound and Cytology Criteria in the Differentiation of Malignant and Benign Thyroid Nodules: TIRADS versus BETHESDA”. Journal of Health Sciences and Medicine 6/2 (March 1, 2023): 405-409. https://doi.org/10.32322/jhsm.1229238.
JAMA
1.Deniz MS, Sarı K, Özturk O. Efficacy analysis between ultrasound and cytology criteria in the differentiation of malignant and benign thyroid nodules: TIRADS versus BETHESDA. J Health Sci Med / JHSM. 2023;6:405–409.
MLA
Deniz, Muzaffer Serdar, et al. “Efficacy Analysis Between Ultrasound and Cytology Criteria in the Differentiation of Malignant and Benign Thyroid Nodules: TIRADS versus BETHESDA”. Journal of Health Sciences and Medicine, vol. 6, no. 2, Mar. 2023, pp. 405-9, doi:10.32322/jhsm.1229238.
Vancouver
1.Muzaffer Serdar Deniz, Kutay Sarı, Oğuz Özturk. Efficacy analysis between ultrasound and cytology criteria in the differentiation of malignant and benign thyroid nodules: TIRADS versus BETHESDA. J Health Sci Med / JHSM. 2023 Mar. 1;6(2):405-9. doi:10.32322/jhsm.1229238

Interuniversity Board (UAK) Equivalency: Article published in Ulakbim TR Index journal [10 POINTS], and Article published in other (excuding 1a, b, c) international indexed journal (1d) [5 POINTS].

The Directories (indexes) and Platforms we are included in are at the bottom of the page.

Note: Our journal is not WOS indexed and therefore is not classified as Q.

You can download Council of Higher Education (CoHG) [Yüksek Öğretim Kurumu (YÖK)] Criteria) decisions about predatory/questionable journals and the author's clarification text and journal charge policy from your browser. https://dergipark.org.tr/tr/journal/2316/file/4905/show







The indexes of the journal are ULAKBİM TR Dizin, ICI World of Journals, DOAJ, Directory of Research Journals Indexing (DRJI), General Impact Factor, ASOS Index, WorldCat (OCLC), MIAR, OpenAIRE, Türkiye Citation Index, Türk Medline Index, InfoBase Index, Scilit, etc.

       images?q=tbn:ANd9GcRB9r6zRLDl0Pz7om2DQkiTQXqDtuq64Eb1Qg&usqp=CAU

500px-WorldCat_logo.svg.png

atifdizini.png

logo_world_of_journals_no_margin.png

images?q=tbn%3AANd9GcTNpvUjQ4Ffc6uQBqMQrqYMR53c7bRqD9rohCINkko0Y1a_hPSn&usqp=CAU

doaj.png  

images?q=tbn:ANd9GcSpOQFsFv3RdX0lIQJC3SwkFIA-CceHin_ujli_JrqBy3A32A_Tx_oMoIZn96EcrpLwTQg&usqp=CAU

ici2.png

asos-index.png

drji.png





The platforms of the journal are Google Scholar, CrossRef (DOI), ResearchBib, Open Access, COPE, ICMJE, NCBI, ORCID, Creative Commons, etc.

COPE-logo-300x199.jpgimages?q=tbn:ANd9GcQR6_qdgvxMP9owgnYzJ1M6CS_XzR_d7orTjA&usqp=CAU

icmje_1_orig.png

cc.logo.large.png

ncbi.pngimages?q=tbn:ANd9GcRBcJw8ia8S9TI4Fun5vj3HPzEcEKIvF_jtnw&usqp=CAU

ORCID_logo.png

1*mvsP194Golg0Dmo2rjJ-oQ.jpeg


Our Journal using the DergiPark system indexed are;

Ulakbim TR Dizin,  Index Copernicus, ICI World of JournalsDirectory of Research Journals Indexing (DRJI), General Impact FactorASOS Index, OpenAIRE, MIAR,  EuroPub, WorldCat (OCLC)DOAJ,  Türkiye Citation Index, Türk Medline Index, InfoBase Index


Our Journal using the DergiPark system platforms are;

Google, Google Scholar, CrossRef (DOI), ResearchBib, ICJME, COPE, NCBI, ORCID, Creative Commons, Open Access, and etc.


Journal articles are evaluated as "Double-Blind Peer Review". 

Our journal has adopted the Open Access Policy and articles in JHSM are Open Access and fully comply with Open Access instructions. All articles in the system can be accessed and read without a journal user.  https//dergipark.org.tr/tr/pub/jhsm/page/9535

Journal charge policy   https://dergipark.org.tr/tr/pub/jhsm/page/10912

Our journal has been indexed in DOAJ as of May 18, 2020.

Our journal has been indexed in TR-Dizin as of March 12, 2021.


17873

Articles published in Journal of Health Sciences and Medicine have open access and are licensed under the Creative Commons CC BY-NC-ND 4.0 International License.